Cross-Cultural Validation of the RECAP of Atopic Eczema Questionnaire in a Swedish Population

Gunnthorunn Sigurdardottir, Mikael Alsterholm, Chris D. Anderson, Maria Bradley, Marihelen Sandström Falk, Emma K. Johansson, Maria Lundqvist, Andreas Sonesson, Åke Svensson, Grigorios Theodosiou, Sophie Vrang, Laura B.von Kobyletzki

Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskriftPeer review

Sammanfattning

A Swedish translation of the patient-reported outcome measure for assessing long-term control of atopic der-matitis, Recap of atopic eczema (RECAP), has not been validated. Cross-cultural translation and multi-centre validation of the translated RECAP questionnaire were therefore performed. Disease severity was assessed using the validated Investigator Global Assessment Scale for atopic dermatitis (vIGA-AD™). The Swedish RECAP was completed by 208 individuals aged 16 years or older with a median age of 36 years (inter-quartile range [IQR] 27–48). The participants consi-dered the questionnaire suitable for assessing eczema control. The median RECAP score (range 0–28) was 12 (IQR 5–19). The mean and median vIGA-AD™ scores (range 0–4) were 2 (standard deviation [SD] 2) and 3 (IQR 2–4), respectively. A correlation between RECAP and the vIGA-AD™ was observed (p < 0.001). There was no significant change in scores for participants who answered the questionnaire twice within 14 days. Over time, improved or worsened eczema, as evaluated by vIGA-AD™, affected RECAP scores significantly (p < 0.001). The study suggests that RECAP can assess AD control in a Swedish clinical setting and shows acceptable reliability.

Originalspråkengelska
Artikelnummeradv38889
TidskriftActa Dermato-Venereologica
Volym104
DOI
StatusPublished - 2024 juni 19

Ämnesklassifikation (UKÄ)

  • Dermatologi och venereologi

Fingeravtryck

Utforska forskningsämnen för ”Cross-Cultural Validation of the RECAP of Atopic Eczema Questionnaire in a Swedish Population”. Tillsammans bildar de ett unikt fingeravtryck.

Citera det här